RIPK3抑制线粒体生物能量学与脂滴动力学在代谢性肝病中的作用
研究在CDAA饮食喂养32周和66周的野生型与Ripk3-/-小鼠及CRISPR-Cas9 Ripk3缺失的脂肪负载永生化肝细胞中评估线粒体与脂滴生物学,并在NAFLD患者队列及PLIN1相关家族性部分脂肪营养不良中分析PLIN1、PLIN5、RIPK3与疾病严重度的关联。Ripk3缺失可挽救线粒体生物合成、生物能量学与功能损伤,上调抗氧化系统,减小脂滴尺寸并增加数量,上调PLIN1和PLIN5;PLIN1上调控制脂滴结构并减轻线粒体应激,与人类NAFLD严重度降低相关。
要点
- Ripk3缺失挽救CDAA饮食小鼠和脂肪负载肝细胞的线粒体生物合成、生物能量学与功能损伤。
- Ripk3-/-肝细胞在游离脂肪酸孵育后脂滴更小且数量更多,并上调PLIN1和PLIN5。
- PLIN1上调控制脂滴结构并减轻线粒体应激,与人类NAFLD严重度降低相关。
核心结论
- Ripk3缺失恢复线粒体生物能量学并影响脂滴动力学。
- 抑制RIPK3在改善NAFLD方面有前景。
研究设计与样本
- 在野生型和Ripk3-/-小鼠喂养胆碱缺乏、氨基酸限定(CDAA)饮食32周和66周中进行线粒体和脂滴生物学功能研究。
- 在CRISPR-Cas9 Ripk3缺失的脂肪负载永生化肝细胞中进行研究。
- 在NAFLD患者队列和PLIN1相关家族性部分脂肪营养不良中分析肝脏PLIN1、PLIN5、RIPK3与疾病严重度的关联。
主要发现
- Ripk3缺失挽救CDAA饮食喂养小鼠和脂肪负载肝细胞中线粒体生物合成、生物能量学和功能的损伤。
- Ripk3缺失伴随抗氧化系统强烈上调,导致体内和体外脂肪负载时氧化应激减轻。
- Ripk3-/-肝细胞与游离脂肪酸孵育后较野生型细胞显示更小尺寸的脂滴且数量更多。
- Ripk3缺失上调脂肪细胞和肝脏中脂滴相关蛋白PLIN1和PLIN5水平。
- PLIN1上调控制Ripk3-/-肝细胞中游离脂肪酸过载时的脂滴结构并减轻线粒体应激,且与人类NAFLD严重度降低相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Receptor-interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD) architecture in NAFLD. APPROACH AND RESULTS: Functional studies evaluating mitochondria and LD biology were performed in wild-type (WT) and Ripk3-/- mice fed a choline-deficient, amino acid-defined (CDAA) diet for 32 and 66 weeks and in CRISPR-Cas9 Ripk3 -null fat-loaded immortalized hepatocytes. The association between hepatic perilipin (PLIN) 1 and 5, RIPK3, and disease severity was also addressed in a cohort of patients with NAFLD and in PLIN1 -associated familial partial lipodystrophy. Ripk3 deficiency rescued impairment in mitochondrial biogenesis, bioenergetics, and function in CDAA diet-fed mice and fat-loaded hepatocytes. Ripk3 deficiency was accompanied by a strong upregulation of antioxidant systems, leading to diminished oxidative stress upon fat loading both in vivo and in vitro. Strikingly, Ripk3-/- hepatocytes displayed smaller size LD in higher numbers than WT cells after incubation with free fatty acids. Ripk3 deficiency upregulated adipocyte and hepatic levels of LD-associated proteins PLIN1 and PLIN5. PLIN1 upregulation controlled LD structure and diminished mitochondrial stress upon free fatty acid overload in Ripk3-/- hepatocytes and was associated with diminished human NAFLD severity. Conversely, a pathogenic PLIN1 frameshift variant was associated with NAFLD and fibrosis, as well as with increased hepatic RIPK3 levels in familial partial lipodystrophy. CONCLUSIONS: Ripk3 deficiency restores mitochondria bioenergetics and impacts LD dynamics. RIPK3 inhibition is promising in ameliorating NAFLD.
引用
- Afonso MB, Islam T, Magusto J, et al. RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Hepatology. 2022. PMID: 36029129. doi:10.1002/hep.32756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。